Is my diabetes type 1 or type 2?

Type 1 diabetes is an autoimmune condition where the body doesn't produce insulin, typically diagnosed in childhood, while Type 2 involves insulin resistance and usually develops in adults. Specific blood tests including C-peptide, autoantibodies, and glucose levels can definitively determine which type you have.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding the Fundamental Differences

If you've been diagnosed with diabetes or are experiencing symptoms that suggest you might have it, determining whether you have Type 1 or Type 2 diabetes is crucial for proper treatment. While both conditions involve problems with blood sugar regulation, they have distinctly different causes, progression patterns, and treatment requirements.

Type 1 diabetes is an autoimmune condition where your immune system mistakenly attacks and destroys the insulin-producing beta cells in your pancreas. This means your body produces little to no insulin, the hormone essential for moving glucose from your bloodstream into your cells. Type 2 diabetes, on the other hand, develops when your body becomes resistant to insulin or doesn't produce enough insulin to maintain normal blood glucose levels.

The distinction between these two types isn't just academic—it directly impacts your treatment plan, lifestyle modifications, and long-term health management strategy. Understanding which type you have helps you and your healthcare team make informed decisions about medication, monitoring frequency, and preventive care. Regular biomarker testing can provide valuable insights into your metabolic health and help track your condition over time.

Type 1 vs Type 2 Diabetes: Key Characteristics

These are typical patterns, but individual cases may vary. Proper testing is essential for accurate diagnosis.
CharacteristicType 1 DiabetesType 2 Diabetes
Typical Age of OnsetTypical Age of OnsetChildren, teens, young adultsAdults over 45 (but increasing in youth)
Speed of OnsetSpeed of OnsetRapid (days to weeks)Gradual (years)
Body WeightBody WeightUsually normal or underweightOften overweight or obese
Insulin ProductionInsulin ProductionLittle to noneNormal or high initially, decreases over time
AutoantibodiesAutoantibodiesPresent in 95% of casesRarely present
Family HistoryFamily HistoryLess common (3-7% if parent has it)Very common (40-70% if parent has it)

These are typical patterns, but individual cases may vary. Proper testing is essential for accurate diagnosis.

Age of Onset and Development Patterns

One of the most notable differences between Type 1 and Type 2 diabetes is when and how quickly they typically develop. Type 1 diabetes often appears suddenly and dramatically, with symptoms developing over weeks or even days. It's most commonly diagnosed in children, teenagers, and young adults, though it can occur at any age—a form called latent autoimmune diabetes in adults (LADA) can develop in people over 30.

Type 2 diabetes usually develops gradually over many years. Most people are diagnosed after age 45, though increasing rates of childhood obesity have led to more Type 2 diagnoses in younger populations. The slow progression means many people have Type 2 diabetes for years before diagnosis, as early stages often present no noticeable symptoms.

The speed of onset can be a helpful clue. If your symptoms appeared suddenly—especially if you're young and not overweight—Type 1 is more likely. If you've had gradually worsening blood sugar readings over time, particularly if you have risk factors like obesity or family history, Type 2 is more probable. However, these patterns aren't absolute rules, which is why proper testing is essential.

Recognizing the Symptoms

While Type 1 and Type 2 diabetes share many symptoms due to elevated blood sugar, there are some differences in how these symptoms present. Both types can cause increased thirst, frequent urination, extreme fatigue, blurred vision, and slow-healing wounds. However, the intensity and timeline of these symptoms often differ significantly.

Type 1 Diabetes Symptoms

Type 1 diabetes symptoms typically appear suddenly and severely. You might experience rapid, unexplained weight loss despite eating normally or even more than usual. This happens because without insulin, your body can't use glucose for energy and starts breaking down fat and muscle for fuel. Diabetic ketoacidosis (DKA) is a serious complication more common in Type 1, causing symptoms like nausea, vomiting, abdominal pain, fruity-smelling breath, and confusion.

Type 2 Diabetes Symptoms

Type 2 diabetes symptoms develop gradually and may be so mild that you don't notice them for years. You might experience increased hunger, darkened skin patches (acanthosis nigricans) in body folds and creases, frequent infections, and numbness or tingling in hands or feet. Many people are diagnosed during routine check-ups before experiencing any symptoms.

Diagnostic Tests That Determine Your Type

While symptoms and risk factors provide clues, specific blood tests are needed to definitively determine whether you have Type 1 or Type 2 diabetes. These tests look at different aspects of your metabolic function and immune system activity to identify the underlying cause of your elevated blood sugar.

C-Peptide Test

The C-peptide test is one of the most important tests for distinguishing between diabetes types. C-peptide is released in equal amounts to insulin when your pancreas produces it naturally. People with Type 1 diabetes typically have very low or undetectable C-peptide levels because their beta cells have been destroyed. Those with Type 2 diabetes usually have normal or high C-peptide levels, indicating their pancreas is still producing insulin but their body isn't using it effectively.

Autoantibody Tests

Autoantibody tests can detect immune system markers that attack insulin-producing cells. The presence of one or more diabetes autoantibodies—such as GAD antibodies, IA-2 antibodies, or insulin autoantibodies—strongly suggests Type 1 diabetes. These antibodies are rarely present in Type 2 diabetes. About 95% of people with Type 1 diabetes test positive for at least one autoantibody at diagnosis.

Additional Blood Tests

Other tests help confirm the diagnosis and assess your overall metabolic health. These include fasting glucose (normal is below 100 mg/dL), HbA1c (which shows average blood sugar over 2-3 months), and oral glucose tolerance tests. While these tests confirm diabetes, they don't distinguish between types on their own. For comprehensive metabolic assessment and ongoing monitoring, regular testing of multiple biomarkers provides the clearest picture of your health status.

Understanding your test results requires medical expertise, but here's a general guide to interpretation.

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

Risk Factors and Family History

Your personal and family medical history provides important context for determining your diabetes type. Type 1 diabetes has a genetic component but is less heritable than Type 2. If you have a parent with Type 1 diabetes, your risk is about 3-5%, compared to 0.4% in the general population. Having a sibling with Type 1 increases your risk to about 6-7%.

Type 2 diabetes has a much stronger genetic link. If one parent has Type 2 diabetes, your lifetime risk is about 40%; if both parents have it, your risk increases to about 70%. However, lifestyle factors play a crucial role in whether genetic predisposition becomes active disease.

Other risk factors differ between types. Type 1 diabetes risk factors include having other autoimmune conditions like thyroid disease or celiac disease, and certain viral infections during childhood. Type 2 diabetes risk factors include obesity (especially abdominal obesity), physical inactivity, poor diet, gestational diabetes history, polycystic ovary syndrome (PCOS), and certain ethnic backgrounds (African American, Hispanic/Latino, Native American, Asian American, and Pacific Islander populations have higher risk).

Treatment Approaches for Each Type

The treatment strategies for Type 1 and Type 2 diabetes differ significantly because of their underlying causes. Understanding these differences is crucial for managing your condition effectively and preventing complications.

Type 1 Diabetes Treatment

Type 1 diabetes always requires insulin therapy since your body cannot produce its own. This involves multiple daily injections or an insulin pump to mimic normal pancreatic function. You'll need to carefully balance insulin doses with food intake and physical activity, monitoring blood sugar frequently throughout the day. Continuous glucose monitors (CGMs) have revolutionized Type 1 management by providing real-time glucose readings and trends.

Beyond insulin, Type 1 management includes carbohydrate counting to match insulin doses to meals, regular blood sugar monitoring (typically 4-10 times daily), and maintaining consistent meal timing. Exercise requires special planning as it can cause blood sugar to drop rapidly. Regular screening for complications like retinopathy, neuropathy, and kidney disease is essential.

Type 2 Diabetes Treatment

Type 2 diabetes treatment often starts with lifestyle modifications—diet changes, increased physical activity, and weight loss can sometimes reverse early Type 2 diabetes or significantly improve blood sugar control. When lifestyle changes aren't sufficient, oral medications like metformin are typically the first pharmaceutical intervention. These medications work in various ways: increasing insulin sensitivity, reducing glucose production by the liver, or helping the pancreas produce more insulin.

As Type 2 diabetes progresses, you might need combination therapy with multiple medications or eventually require insulin. However, many people with Type 2 diabetes can manage their condition for years or decades without insulin. Regular monitoring is important but typically less frequent than with Type 1—perhaps checking blood sugar once daily or a few times per week, depending on your treatment plan.

Special Considerations and Misdiagnosis

Sometimes determining diabetes type isn't straightforward. Several scenarios can complicate diagnosis, and misdiagnosis occurs more often than many people realize. Studies suggest that 5-10% of adults diagnosed with Type 2 diabetes actually have Type 1, particularly those diagnosed under age 50 who aren't significantly overweight.

LADA (Latent Autoimmune Diabetes in Adults) is sometimes called Type 1.5 diabetes because it shares features of both types. It's an autoimmune condition like Type 1 but progresses slowly like Type 2. People with LADA are often initially misdiagnosed with Type 2 because they're adults who may still produce some insulin initially. However, they typically require insulin treatment within a few years of diagnosis.

MODY (Maturity Onset Diabetes of the Young) is a rare genetic form of diabetes that accounts for 1-2% of all diabetes cases. It's caused by mutations in single genes and often runs strongly in families, affecting multiple generations. MODY is frequently misdiagnosed as Type 1 or Type 2 but may require different treatment approaches.

If your diabetes doesn't follow typical patterns—for instance, if you're lean but diagnosed with Type 2, or if standard Type 2 medications aren't working well—consider asking for additional testing. Getting the correct diagnosis ensures you receive the most appropriate treatment. For those interested in understanding their metabolic health comprehensively, including early detection of diabetes risk factors, regular biomarker monitoring can provide valuable insights into your body's insulin production and glucose management capabilities.

Living with Your Diagnosis

Regardless of which type of diabetes you have, receiving a diagnosis can feel overwhelming. However, with proper management, people with both Type 1 and Type 2 diabetes can live long, healthy lives. The key is understanding your specific condition, working closely with your healthcare team, and staying informed about your treatment options.

Education is crucial for both types. Diabetes self-management education (DSME) programs can teach you essential skills like blood sugar monitoring, medication management, meal planning, and recognizing and treating high and low blood sugar. Many people find that connecting with others who have diabetes through support groups or online communities provides valuable emotional support and practical tips.

Technology has transformed diabetes management for both types. CGMs, insulin pumps, smart insulin pens, and diabetes management apps can simplify daily care and improve outcomes. These tools can help you identify patterns, predict trends, and make more informed decisions about your health.

Remember that diabetes management is highly individual. What works for someone else with the same type of diabetes might not work for you. Regular monitoring of your blood sugar and other health markers helps you and your healthcare team fine-tune your treatment plan. Consider uploading your existing blood test results to SiPhox Health's free analysis service for personalized insights into your metabolic health and actionable recommendations based on your unique profile.

Moving Forward with Confidence

Determining whether you have Type 1 or Type 2 diabetes is the first step toward effective management. While the distinction might seem complex, modern diagnostic tests can usually provide a clear answer. If you're unsure about your diagnosis or if your treatment doesn't seem to be working as expected, don't hesitate to seek a second opinion or ask for additional testing.

The most important thing is to take an active role in your health. Whether you have Type 1 or Type 2 diabetes, consistent management, regular monitoring, and a strong partnership with your healthcare team are the foundations of living well with diabetes. With the right knowledge, tools, and support, you can effectively manage your condition and maintain excellent quality of life.

References

  1. American Diabetes Association. (2024). Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2024. Diabetes Care, 47(Supplement 1), S20-S42.[Link][DOI]
  2. Jones, A. G., & Hattersley, A. T. (2023). The clinical utility of C-peptide measurement in the care of patients with diabetes. Diabetic Medicine, 40(7), e14508.[Link][PubMed][DOI]
  3. Buzzetti, R., Tuomi, T., Mauricio, D., et al. (2022). Management of Latent Autoimmune Diabetes in Adults: A Consensus Statement From an International Expert Panel. Diabetes, 71(9), 1904-1914.[PubMed][DOI]
  4. Shields, B. M., Peters, J. L., Cooper, C., et al. (2023). Can clinical features be used to differentiate type 1 from type 2 diabetes? A systematic review of the literature. BMJ Open, 13(11), e055011.[Link][PubMed][DOI]
  5. Thomas, N. J., Lynam, A. L., Hill, A. V., et al. (2023). Type 1 diabetes defined by severe insulin deficiency occurs after 30 years of age and is commonly treated as type 2 diabetes. Diabetologia, 66(7), 1250-1259.[PubMed][DOI]
  6. Redondo, M. J., Hagopian, W. A., Oram, R., et al. (2022). The clinical consequences of heterogeneity within and between different diabetes types. Diabetologia, 65(10), 1599-1612.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my C-peptide and glucose levels at home?

You can test your C-peptide and glucose levels at home with SiPhox Health's Heart & Metabolic Program, which includes C-peptide, HbA1c, and comprehensive metabolic markers. The program provides lab-quality results with personalized insights to help you understand your diabetes risk and metabolic health.

Can Type 2 diabetes turn into Type 1 diabetes?

No, Type 2 diabetes cannot turn into Type 1 diabetes. They are distinct conditions with different causes. However, people with Type 2 diabetes may eventually need insulin if their pancreas produces less insulin over time, but this doesn't mean they've developed Type 1 diabetes.

What's the most accurate test to determine diabetes type?

The C-peptide test combined with autoantibody testing provides the most accurate determination. C-peptide shows how much insulin your body produces, while autoantibody tests detect immune markers specific to Type 1 diabetes. These tests together can definitively distinguish between Type 1 and Type 2.

Can you have both Type 1 and Type 2 diabetes?

You cannot have both types simultaneously, but people with Type 1 diabetes can develop insulin resistance (a hallmark of Type 2), sometimes called 'double diabetes.' This requires managing both insulin deficiency and insulin resistance.

How long does it take to get a definitive diagnosis?

With proper testing, you can usually determine your diabetes type within a few days to a week. Initial blood sugar tests can confirm diabetes immediately, while specific tests like C-peptide and autoantibodies may take several days for results.

Is genetic testing available to predict diabetes type?

While genetic testing can identify some risk factors, it cannot definitively predict or diagnose diabetes type. Current diagnosis relies on blood tests that measure actual pancreatic function and immune markers rather than genetic predisposition.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details